CTRI/2020/09/027944尚未招募3 期
An open label, prospective comparative study to evaluate potential of the proposed therapy (Tablet Cefixime 200 mg/Tablet Ivermectin 12 mg/Tablet Montelukast 10mg/Syrup Ascoril LS 5 ml) in adults with mild symptomatic COVID-19 patients receiving the standard treatment (Tablet Cefixime 200 mg/Vitamin C, MVBC/Antacids) of COVID infection. - Add on therapy/COVID-19/2020
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of both Gender aged more than 18 years old.
- •2.Willing and able to provide written informed consent.
- •3.Patients with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV2 / COVID) infection confirmed by RT Polymerase chain reaction (RT-PCR) test
- •4.Currently hospitalized and requiring medical care for COVID-19
- •5.Peripheral capillary oxygen saturation (SpO2) > 94% on room air at screening
排除标准
- •1.Subjects having less than 18 years of age
- •2.Drug atopy subjects
- •3.Private positive patients/ Truenaat positive/ Antigen positive
- •4.Critical comorbities
研究者
相似试验
已完成
3 期
A clinical trial to study the effects of Recombinant Human Erythropoietin therapy in management of anemia in patients suffering from Chronic Renal Failure.CTRI/2009/091/000786upin Limited India
进行中（未招募）
1 期
Dermatitis StudyEUCTR2017-001574-42-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd123
尚未招募
2 期
A study to evaluate the efficacy of Bharangyadi Madhuka and Talishadi Churna in the management of Tamaka Shwas(Bronchial Asthma)CTRI/2024/07/071146Institute For Ayurved Studies and Research
已完成
3 期
Clinical trial on Women health PCOS conditionsCTRI/2021/04/033101Jagdale industries pvt Ltd60
已完成
3 期
Clinical trial on Pregnant WomaCTRI/2021/04/033099Jagdale industries pvt Ltd60